Cipla
Search results
Insights from the leading minds in our industry. Explore. The Lupin Foundation works in over 4,500 villages to ensure sustainable development. Our Mission. Delivering on our promise toward innovative science and healthcare for more than five decades. How We Began.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
Lupin is a confluence ground for Passion and Profession. We believe that passion is the fuel for propelling one’s career graph. We capitalize and nurture the performance potential of our people to garner superlative Patient Xperiences.
Established in 1968 by our visionary founder, Dr. Desh Bandhu Gupta, Lupin has evolved from humble beginnings to become a global healthcare leader. Headquartered in Mumbai, India, we have expanded our footprint across the U.S., LATAM, APAC and EMEA regions, operating in over 100 countries and offering adiverse portfolio of over 1,000 products.
Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a...
Lupin Limited Stock Price Today, Live NSE Share Price: Get the latest Lupin Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
Get the latest Lupin Ltd (LUPIN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Find the latest Lupin Limited (LUPIN.NS) stock quote, history, news and other vital information to help you with your stock trading and investing.
3 days ago · Shares of Lupin hit a multi-year high at Rs 1,749, soaring 7 per cent on the BSE in Thursday’s intra-day trade backed by heavy volumes on expectation of healthy earnings. ... which will ensure a limited earnings dip in FY2027E after a strong FY2026E,” the brokerage firm said in its stock update. Analysts believes there is still a possibility of further positive surprises if Lupin continues to gain share in gSpiriva as well, if there is lower-than-expected hit from Albuterol competition.
